Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) EBT Margin (2016 - 2026)

Biomerica's EBT Margin history spans 17 years, with the latest figure at 132.12% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 2783.0% to 132.12% in Q1 2026 year-over-year; TTM through Feb 2026 was 96.0%, a 1065.0% decrease, with the full-year FY2025 number at 93.62%, up 1600.0% from a year prior.
  • EBT Margin hit 132.12% in Q1 2026 for Biomerica, down from 108.68% in the prior quarter.
  • Over the last five years, EBT Margin for BMRA hit a ceiling of 0.36% in Q3 2025 and a floor of 205.47% in Q2 2025.
  • Historically, EBT Margin has averaged 101.92% across 5 years, with a median of 108.68% in 2025.
  • Biggest five-year swings in EBT Margin: surged 12921bps in 2022 and later tumbled -14404bps in 2023.
  • Tracing BMRA's EBT Margin over 5 years: stood at 109.65% in 2022, then increased by 13bps to 95.66% in 2023, then soared by 39bps to 58.25% in 2024, then plummeted by -87bps to 108.68% in 2025, then decreased by -22bps to 132.12% in 2026.
  • Business Quant data shows EBT Margin for BMRA at 132.12% in Q1 2026, 108.68% in Q4 2025, and 0.36% in Q3 2025.